|
|
川井一輝 研究業績一覧 (16件)
論文
-
K. Nishimura,
S. Harrison,
K. Kawai,
T. Morita,
K. Miura,
S. Okada,
H. Nakamura.
Iodophenyl-conjugated closo-dodecaborate as a promising small boron molecule that binds to serum albumin and accumulates in tumor,
BIOORG. MED. CHEM. LETT.,
Vol. 72,
128869,
Sept. 2022.
-
A. M.Hughes,
J. A. Goldfinger,
M. A. Palmieri,
P. Ramos,
I. S. Santa Cruz,
L. De Leo,
M. A. Garabalino,
S. I. Thorp,
P. Curotto,
E. C.C. Pozzi,
K. Kawai,
S. Sato,
M. E. Itoiz,
V.A. Trivillin,
J. S. Guidobono,
H. Nakamura,
A. E. Schwint.
Boron neutron capture therapy (BNCT) mediated by maleimide-functionalized closo-dodecaborate albumin conjugates (MID:BSA) for oral cancer: Biodistribution studies and in vivo BNCT in the hamster cheek pouch oral cancer model,
Life (Basel),
12,
7,
1082,
July 2022.
-
H. Kashiwagi,
S. Kawabata,
K. Yoshimura,
Y. Fukuo,
T. Kanemitsu,
K. Takeuchi,
R. Hiramatsu,
K. Nishimura,
K. Kawai,
T. Takata,
H. Tanaka,
T. Watanabe,
M. Suzuki,
S. Miyatake,
H. Nakamura,
M. Wanibuchi.
Boron neutron capture therapy using dodecaborated albumin conjugates with maleimide is effective in a rat glioma model,
Investigational new drugs,
Nov. 2021.
-
Yasunobu Asawa,
Kei Nishida,
Kazuki Kawai,
Kiyotaka Domae,
Hyun Seung Ban,
Akihiro Kitazaki,
Hiroya Asami,
Jun-Ya Kohno,
Satoshi Okada,
Hiraku Tokuma,
Daisuke Sakano,
Shoen Kume,
Masaru Tanaka,
Hiroyuki Nakamura.
Carborane as an Alternative Efficient Hydrophobic Tag for Protein Degradation,
Bioconjugate Chemistry,
Nov. 2021.
公式リンク
-
Kazuki Kawai,
Kai Nishimura,
Satoshi Okada,
Shinichi Sato,
Minoru Suzuki,
T. Takata,
Hiroyuki Nakamura.
Cyclic RGD-Functionalized closo-Dodecaborate Albumin Conjugates as Integrin Targeting Boron Carriers for Neutron Capture Therapy,
Mol. Pharm.,
Vol. 17,
No. 10,
pp. 3740–3747,
Aug. 2020.
-
Hiroyuki Nakamura,
Shunsuke Kikuchi,
Kazuki Kawai,
Satomu Ishii,
Shinichi Sato.
closo-Dodecaborate-conjugated human serum albumins: preparation and in vivo selective boron delivery to tumor,
Pure Appl. Chem.,
Vol. 90,
No. 4,
745～753,
Feb. 2018.
国内会議発表 (査読有り)
国際会議発表 (査読なし・不明)
-
Hiroyuki Nakamura,
Kazuki Kawai,
Kai Nishimura,
Satoshi Okada,
Takushi Takata,
Minoru Suzuki.
Albumin-Based Boron Delivery for Active Targeting to Tumor,
22nd Taiwan-Japan Neutron Capture Therapy Academic Conference of Elite, oral (online, Taiwan),
Oct. 2020.
-
Hiroyuki Nakamura,
Kazuki Kawai,
Takushi Takata,
Minoru Suzuki.
Development of Cyclic RGD-functionalized Maleimide-closo-dodecaborate Albumin Conjugate (cRGD-MID-AC) as a Tumor Targeting Boron Carrier,
yBNCT10,
Sept. 2019.
-
Andrea Monti Hughes,
Jessica A Goldfinger,
Marcela A Garabalino,
Iara Santa Cruz,
Veronica A Trivillin,
Emiliano Cc Pozzi,
Kazuki Kawai,
Hiroyuki Nakamura.
Biodistribution studies of maleimide-functionalized closo-dodecaborate albumin conjugates(MID:BSA) in the hamster cheek pouch oral cancer model,
8th International Congress on Neutron Capture Therapy,
Oct. 2018.
-
Kazuki Kawai,
Shinichi Sato,
Hiroyuki Nakamura.
Development of cyclic RGD-functionalized maleimide-containing closo-dodecaborate albumin conjugate (MID-AC) as an active tumor targeting boron carrier for neutron capture therapy,
18th International Congress on Neutron Capture Therapy,
Oct. 2018.
国内会議発表 (査読なし・不明)
-
川井一輝,
佐藤伸一,
中村浩之.
中性子捕捉療法のためのcyclicRGDペプチドを用いた腫瘍選択的なホウ素送達法の開発,
第35回DDS学会学術集会,
July 2019.
-
中村浩之,
川井一輝,
高田卓志,
鈴木実.
cRGDペプチドを利用したアルブミンーホウ素キャリアの腫瘍ターゲティング,
第25回癌治療増感研究会,
June 2019.
-
川井一輝,
佐藤伸一,
中村浩之.
中性子捕捉療法を志向した腫瘍アクティブターゲティングのための cyclic RGD ペプチド結合ホウ素化アルブミンの開発,
日本化学会第99春季年会,
Mar. 2019.
-
Kazuki Kawai,
Shinichi Sato,
Hiroyuki Nakamura.
The Development of dual modified albumin with cyclic RGD and maleimide-functionalized closo-dodecaborate as an active tumor targeting boron carrier for neutron capture therapy,
1st GLowing Polymer Symposium in KANTO,
Dec. 2018.
-
川井一輝,
佐藤伸一,
中村浩之.
腫瘍アクティブターゲティングを志向したcyclic RGD peptide 結合ホウ素化アルブミンの開発,
第15回日本中性子捕捉療法学会,
Sept. 2018.
[ BibTeX 形式で保存 ]
[ 論文・著書をCSV形式で保存
]
[ 特許をCSV形式で保存
]
|
各種検索
サポート
ヘルプ
